The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial
LEADER Publication Committee on behalf of the LEADER Trial Investigators
Dyk ned i forskningsemnerne om 'The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial'. Sammen danner de et unikt fingeraftryk.